In vitro cell culture studies show that all activating BRAF mutants are RAS-independent 21: neither RAS inhibition 21 nor EGFR inhibition 22,23 was able to inhibit mutant-BRAF-induced ERK phosphorylation in BRAF-mutant human CRC cell lines. Here, EGFR is linked to colorectal carcinoma.